ArticleiScience2026
Contrastive learning of dynamic processing body formation reveals undefined mechanisms of approved compounds.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Membraneless organelles (MLOs) are liquid-like compartments that organize cellular functions through liquid-liquid phase separation of proteins and RNA. Their regulation is crucial for RNA metabolism, stress response, and signaling, yet leveraging their full spatial and quantitative diversity for phenotypic screening remains challenging. Here, we present processing body (PB)-scope, an unsupervised deep-learning framework for imaging-based screening of PBs, a representative MLO. The model was trained on >400,000 single-cell confocal images from a colon cancer cell line treated with 280 compounds. PB-scope enabled precise drug classification based on multiple PB features, including number, size, and spatial distribution. This approach uncovered phenotypic patterns that were previously obscured by the subtle and dynamic nature of PBs and highlighted a set of compounds that converge on Janus kinase (JAK) signaling as a regulator of PB dynamics. PB-scope is readily extensible to other MLOs, offering broad applicability in this emerging field of cell biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.